InVivoMAb anti-human CTLA-4 (CD152)
BE0190
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human CTLA-4 (CD152)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDBN13
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostMouse
- IsotypeIgG2a
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. Bhela S et al., 2015 Mar 1, J ImmunolRead this paper
- Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. Gideon HP et al., 2015 Jan, PLoS PathogRead this paper
- Stromal cells B7-1 is a key stimulatory molecule for interleukin-10 production by HOZOT, a multifunctional regulatory T-cell line. Otani T et al., 2011 Feb, Immunol Cell BiolRead this paper
- HIV-1 impairs in vitro priming of naive T cells and gives rise to contact-dependent suppressor T cells. Che KF et al., 2010 Aug, Eur J ImmunolRead this paper
- Antigen-induced regulatory T cells in HBV chronically infected patients. Barboza L et al., 2007 Nov 10, VirologyRead this paper
- CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Pistillo MP et al., 2003 Jan 1, BloodRead this paper
